findmyKOL
Clinical trialNCT02469519CompletedPhase 2/PHASE3Interventional

Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes

SponsorPediatrixEnrollment194Premature Birth
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of South Alabama Medical Center

    Mobile, Alabama, United States

  • Phoenix Perinatal Associates

    Phoenix, Arizona, United States

  • Long Beach Memorial Medical Center

    Long Beach, California, United States

  • Good Samaritan Hospital

    San Jose, California, United States

  • Presbyterian/st Luke'S Hospital

    Denver, Colorado, United States

  • Ochsner Clinic Foundation

    New Orleans, Louisiana, United States

  • Lousiana State University Health Science

    Shreveport, Louisiana, United States

  • University of Tennessee Medical Center

    Knoxville, Tennessee, United States

  • Swedish Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Betamethasone - ACTIVE
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Mar 2016
Primary completion
15 Aug 2022
Completion
31 Oct 2022
Last update posted
15 Dec 2022
Registered enrollment
194
Registry id
NCT02469519
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.